Augmented analgesic effect of tyramine or octopamine in combination with lidocaine is mediated with α-adrenergic receptors.

IF 2.2 3区 医学 Q3 PHYSIOLOGY
An-Kuo Chou, Chong-Chi Chiu, Yu-Wen Chen, Ching-Hsia Hung, Jhi-Joung Wang
{"title":"Augmented analgesic effect of tyramine or octopamine in combination with lidocaine is mediated with α-adrenergic receptors.","authors":"An-Kuo Chou, Chong-Chi Chiu, Yu-Wen Chen, Ching-Hsia Hung, Jhi-Joung Wang","doi":"10.1152/ajpregu.00225.2024","DOIUrl":null,"url":null,"abstract":"<p><p>Although norepinephrine is known to enhance the antinociceptive effect of the local anesthetic lidocaine, the effects of two precursors of norepinephrine, tyramine and octopamine, on the antinociceptive potency of lidocaine are not known. We aimed to investigate cutaneous antinociceptive interactions and mechanism of action of tyramine and octopamine, and their respective co-injections with lidocaine, in comparison with norepinephrine. Cutaneous nociceptive blockade in rats was quantified by the blockage of cutaneous trunci muscle reflexes induced by needle pinpricks. Isobolographic analysis was employed to estimate the interactions between lidocaine and drugs (tyramine, octopamine, or norepinephrine). Phentolamine was added to a two-drug combination. At ED<sub>75</sub> (75% effective dose), subcutaneous injection of tyramine and lidocaine provoked 73% and 77% nociceptive blockade. After isobolographic analysis, the theoretical ED<sub>50</sub> was significantly greater than the experimental ED<sub>50</sub> in both octopamine-lidocaine combination and norepinephrine-lidocaine combination (<i>p</i><0.01), but not in tyramine-lidocaine combination. Lidocaine (ED<sub>95</sub>) in combination with tyramine (30 μmole), octopamine (12 μmole), or norepinephrine (0.007 μmole) prolonged the duration of nociceptive blockade (<i>p</i><0.05). The addition of phentolamine (0.06 μmole) to a combination of tyramine (30 μmole) and lidocaine (ED<sub>95</sub>), a combination of octopamine (12 μmole) and lidocaine (ED<sub>95</sub>), or a combination of n orepinephrine (0.007 μmole) and lidocaine (ED<sub>95</sub>) showed a nociceptive blocking effect similar to that of lidocaine (ED<sub>95</sub>) alone. Tyramine and octopamine presented dose-dependent cutaneous nociceptive blockades. Tyramine-lidocaine combination produced an additive effect. The combination of octopamine-lidocaine and norepinephrine-lidocaine showed synergistic effects that was inhibited by phentolamine, suggesting that this synergistic effect is mediated with alpha-adrenergic receptors.</p>","PeriodicalId":7630,"journal":{"name":"American journal of physiology. Regulatory, integrative and comparative physiology","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of physiology. Regulatory, integrative and comparative physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1152/ajpregu.00225.2024","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Although norepinephrine is known to enhance the antinociceptive effect of the local anesthetic lidocaine, the effects of two precursors of norepinephrine, tyramine and octopamine, on the antinociceptive potency of lidocaine are not known. We aimed to investigate cutaneous antinociceptive interactions and mechanism of action of tyramine and octopamine, and their respective co-injections with lidocaine, in comparison with norepinephrine. Cutaneous nociceptive blockade in rats was quantified by the blockage of cutaneous trunci muscle reflexes induced by needle pinpricks. Isobolographic analysis was employed to estimate the interactions between lidocaine and drugs (tyramine, octopamine, or norepinephrine). Phentolamine was added to a two-drug combination. At ED75 (75% effective dose), subcutaneous injection of tyramine and lidocaine provoked 73% and 77% nociceptive blockade. After isobolographic analysis, the theoretical ED50 was significantly greater than the experimental ED50 in both octopamine-lidocaine combination and norepinephrine-lidocaine combination (p<0.01), but not in tyramine-lidocaine combination. Lidocaine (ED95) in combination with tyramine (30 μmole), octopamine (12 μmole), or norepinephrine (0.007 μmole) prolonged the duration of nociceptive blockade (p<0.05). The addition of phentolamine (0.06 μmole) to a combination of tyramine (30 μmole) and lidocaine (ED95), a combination of octopamine (12 μmole) and lidocaine (ED95), or a combination of n orepinephrine (0.007 μmole) and lidocaine (ED95) showed a nociceptive blocking effect similar to that of lidocaine (ED95) alone. Tyramine and octopamine presented dose-dependent cutaneous nociceptive blockades. Tyramine-lidocaine combination produced an additive effect. The combination of octopamine-lidocaine and norepinephrine-lidocaine showed synergistic effects that was inhibited by phentolamine, suggesting that this synergistic effect is mediated with alpha-adrenergic receptors.

酪胺或章鱼胺与利多卡因联用时增强镇痛作用是通过α-肾上腺素能受体介导的。
虽然已知去甲肾上腺素能增强局部麻醉剂利多卡因的抗伤害性作用,但去甲肾上腺素的两种前体酪胺和章鱼胺对利多卡因的抗伤害性效力的影响尚不清楚。我们的目的是研究酪胺和章鱼胺的相互作用和作用机制,以及它们各自与利多卡因的联合注射,并与去甲肾上腺素进行比较。通过针刺对大鼠皮肤干肌反射的阻断,定量观察皮肤伤害性阻滞。采用等密度分析来估计利多卡因与药物(酪胺、章鱼胺或去甲肾上腺素)之间的相互作用。苯妥拉明被加入到两种药物的组合中。在ED75(75%有效剂量)时,皮下注射酪胺和利多卡因分别引起73%和77%的伤害性阻滞。等密度分析表明,章鱼胺-利多卡因联用组和去甲肾上腺素-利多卡因联用组(p95)分别与酪胺(30 μmol)、章鱼胺(12 μmol)、去甲肾上腺素(0.007 μmol)联用组(p95)、章鱼胺(12 μmol)和利多卡因联用组(ED95)的理论ED50均显著大于实验ED50。或n -肾上腺素(0.007 μmol)与利多卡因(ED95)联用均表现出与利多卡因(ED95)单用相似的伤害阻断作用。酪胺和章鱼胺呈现剂量依赖性皮肤伤害性阻滞。酪胺-利多卡因联合用药产生加性效应。章鱼胺-利多卡因与去甲肾上腺素-利多卡因联用表现出协同作用,但被酚妥拉明抑制,表明这种协同作用是由α -肾上腺素能受体介导的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
3.60%
发文量
145
审稿时长
2 months
期刊介绍: The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology publishes original investigations that illuminate normal or abnormal regulation and integration of physiological mechanisms at all levels of biological organization, ranging from molecules to humans, including clinical investigations. Major areas of emphasis include regulation in genetically modified animals; model organisms; development and tissue plasticity; neurohumoral control of circulation and hypertension; local control of circulation; cardiac and renal integration; thirst and volume, electrolyte homeostasis; glucose homeostasis and energy balance; appetite and obesity; inflammation and cytokines; integrative physiology of pregnancy-parturition-lactation; and thermoregulation and adaptations to exercise and environmental stress.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信